Strengthening regulatory systems for medicines in a changed world: where do we go from here?

O'Brien, Julie; Lumsden, Rebecca; Macdonald, Judith

O'Brien, Julie; Lumsden, Rebecca; Macdonald, Judith.

O'Brien J; Global Regulatory Policy and Intelligence, Global Regulatory Affairs, Pfizer Healthcare Ireland, Dublin, Ireland julie.obrien@pfizer.com.
Lumsden R; Global Regulatory Policy and Intelligence, Global Regulatory Affairs, Pfizer Ltd, Tadworth, Surrey, UK.
Macdonald J; Global Regulatory Policy and Intelligence, Global Regulatory Affairs, Pfizer Ltd, Tadworth, Surrey, UK.

BMJ Glob Health ; 6(1)2021 01.

Article in English | MEDLINE | ID: covidwho-1388499

Subject(s)

Global Health/legislation & jurisprudence; Legislation, Drug; Public Health/legislation & jurisprudence; Antiviral Agents; COVID-19; Humans; Pandemics; SARS-CoV-2

Keywords

COVID-19; health policy; health systems; public health

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Public Health / Global Health / Legislation, Drug Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: BMJGH-2020-004680

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google